Therapure Biopharma Inc. Announces Collaboration with Mount Sinai Hospital

Share Article

Therapure to support development projects.

Therapure Biopharma offers us an opportunity to advance our development projects in a cost-effective manner while maintaining rigorous quality standards.

Thomas Wellner, President and CEO of Therapure Biopharma Inc. today announced the signing of a multi-year agreement to collaborate with Mount Sinai Hospital and support development projects being conducted by the Hospital.

Under the terms of the agreement, Therapure Biopharma will provide a clean room processing facility and technical staff to be located at Therapure Biopharma's Meadowpine facility.

"The requirements of Mount Sinai are a very good fit with our capabilities," said Thomas Wellner. "Our recent investment in pilot-scale clean rooms enables us to provide these services in a cost-effective manner for customers. We are very pleased that Mount Sinai Hospital has chosen Therapure Biopharma as their partner for these development projects."

"Mount Sinai is pleased to be working with Therapure Biopharma," said Neil Closner, Vice President, Business Development. "Therapure Biopharma offers us an opportunity to advance our development projects in a cost-effective manner while maintaining rigorous quality standards."

About Therapure Biopharma:

Therapure Biopharma Inc. is an integrated biopharmaceutical company that develops, manufactures, purifies, and packages therapeutic proteins. Therapure Biopharma is also a specialist in the development of therapeutics derived from a wide range of biological sources, including hemoglobin, a blood protein. As a contract development and manufacturing organization (CDMO) Therapure Biopharma applies scientific, manufacturing, and downstream purification expertise with an intimate understanding of advanced biology, complex proteins, and regulatory processes to develop effective and innovative solutions to advance products from discovery to market.

For more information, please visit: http://www.therapurebio.com

About Mount Sinai Hospital

Mount Sinai Hospital is an internationally recognized, 472-bed acute care academic health sciences centre affiliated with the University of Toronto. It is known for excellence in the provision of compassionate patient care, innovative education, and leading-edge research. Mount Sinai's Centres of Excellence include the Lawrence and Frances Bloomberg Centre for Women's and Infants' Health; Christopher Sharp Centre for Surgery & Oncology; Daryl A. Katz Centre for Acute and Chronic Medicine; Centre for Laboratory Medicine and Infection Control, and the Samuel Lunenfeld Research Institute. For more information about Mount Sinai Hospital, please visit us online at http://www.mountsinai.on.ca

Media Contacts:

Thomas Wellner, President and CEO
Therapure Biopharma Inc.
+1 905-286-6204
ceo(at)therapurebio.com

Melissa Mcdermott
Mount Sinai Hospital
Toronto Ontario
416 586 4800 x3161
mmcdermott(at)mtsinai.on.ca

###

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Peter Winkley
Therapure Biopharma Inc.
905-286-6217 ext. L5N 8H9
Email >
Visit website